Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-058742

Y-mAbs Therapeutics, Inc. · YMAB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ashu Tyagi
Director
Period of report
Sep 25, 2018
Accepted (ET)
Sep 26, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001722964

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Sep 25, 2018P430,174$16.00A1,392,740ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses